Your browser doesn't support javascript.
Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Herishanu, Yair; Avivi, Irit; Levi, Shai; Shefer, Gabi; Bronstein, Yotam; Moshiashvili, Miguel Morales; Ziv, Tomer; Scarfò, Lydia; Perry, Chava; Ghia, Paolo.
  • Herishanu Y; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Avivi I; Department of Hematology, and.
  • Levi S; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Shefer G; Department of Hematology, and.
  • Bronstein Y; Department of Hematology, and.
  • Moshiashvili MM; Department of Endocrinology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Ziv T; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Scarfò L; Department of Hematology, and.
  • Perry C; Department of Endocrinology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Ghia P; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Blood Adv ; 6(1): 148-151, 2022 01 11.
Article in English | MEDLINE | ID: covidwho-1455908

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021005998

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021005998